Exelixis, Inc.
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients…
Biotechnology
US, Alameda [HQ]
Lobbying Analysis
Lobbying · US Senate · InfluenceHistory
Download| FY | Quarter | Expense For Lobby Disclosure | LDA Reference |
|---|---|---|---|
| 2024 | 1 | $5,000,000 | LD-2 : 04/23/24 |
| 2024 | 1 | $6,000,000 | LD-2 : 04/22/24 |
| 2023 | 4 | $5,000,000 | LD-2 : 01/23/24 |
| 2023 | 4 | $6,000,000 | LD-2 : 01/19/24 |
| 2023 | 4 | $6,000,000 | LD-2 : 01/18/24 |